<?xml version="1.0" encoding="UTF-8"?>
<p>Practices not recommended by the WHO increase the associated costs [
 <xref rid="pone.0219287.ref015" ref-type="bibr">15</xref>]. Nevertheless, recent economic literature regarding the transfusion of blood components is scarce and does not include any research that describes the economic impact of not following WHO guidelines for the transfusion of blood components (platelets, fresh frozen plasma–FFP, and packed red cells–PRC). The aim of this study was to describe the use of blood components in clinical practice and to assess its economic and patient health impact through hospitalised dengue cases generated by adherence or a lack of adherence to WHO recommendations.
</p>
